Merck Serono

Bedfont Cross, Stanwell Road, Feltham, Middlesex, TW14 8NX, UK
Telephone: +44 (0)208 818 7200
Fax: +44 (0)208 818 7267
Medical Information Direct Line: +44 (0)208 818 7373
Medical Information e-mail: medinfo.uk@merckserono.net
Medical Information Fax: +44 (0)208 818 7274

Summary of Product Characteristics last updated on the eMC: 27/07/2009
SPC Pergoveris 150 IU/75 IU powder and solvent for solution for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 27/07/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Date of revision of text on the SPC:   01-Jul-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Change to Section 7 - MA Holder

From

Serono Europe Limited

To

Merck Serono Europe Limited

Updated on 03/10/2007 and displayed until 27/07/2009
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
   follitropin alpha
   lutropin alfa